Exact Mass: 423.0099

Exact Mass Matches: 423.0099

Found 55 metabolites which its exact mass value is equals to given mass value 423.0099, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cephapirin

(6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(pyridin-4-ylsulfanyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C17H17N3O6S2 (423.0559)


Cephapirin is an injectable, first-generation cephalosporin antibiotic that has a wide spectrum of activity against gram-positive and gram-negative organisms. The bactericidal activity of cephapirin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cephapirin is more resistant to beta-lactamases than the penicillins, and therefore is effective against staphylococci, with the exception of methicillin-resistant staphylococci. Cephapirin is FDA approved for use in food-producing animals, especially dairy cattle. Cephapirin is used for the treatment of mastitis in cows. Production for use in humans has been discontinued in the United States. It is marketed under the trade name Cefadyl. Active against gram-positive and -negative bacteria (vet. use). FDA approved for use in food producing animals, especies dairy cattle. It is used for the treatment of mastitis in cows J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Glucoiberin

{[(E)-(4-methanesulfinyl-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxy}sulfonic acid

C11H21NO10S3 (423.0328)


Glucoiberin belongs to the class of organic compounds known as alkylglucosinolates. These are organic compounds containing a glucosinolate moiety that carries an alkyl chain. Glucoiberin is an extremely weak basic (essentially neutral) compound (based on its pKa). Glucoiberin has been detected, but not quantified in, several different foods, such as capers, cauliflowers, cabbages, Brassicas, and Chinese cabbages. This could make glucoiberin a potential biomarker for the consumption of these foods. Glucoiberin is isolated from the seeds of Brassica oleracea and other crucifers. Isolated from seeds of Brassica oleracea and other crucifers. Glucoiberin is found in many foods, some of which are white cabbage, cabbage, broccoli, and brussel sprouts. Acquisition and generation of the data is financially supported in part by CREST/JST.

   

Calicheamicinone

Methyl N-[(1R,4Z,8S,13E)-1,8-dihydroxy-13-[2-(methyltrisulfanyl)ethylidene]-11-oxo-10-bicyclo[7.3.1]trideca-4,9-dien-2,6-diynyl]carbamate

C18H17NO5S3 (423.0269)


   

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] 4-methylsulfinyl-N-sulfooxy-butanimidothioate

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] 4-methylsulfinyl-N-sulfooxy-butanimidothioate

C11H21NO10S3 (423.0328)


   

5-Amino-4-hydroxy-3-(phenylazo)-2,7-naphthalenedisulfonic acid

5-Amino-4-hydroxy-3-[(e)-2-phenyldiazen-1-yl]naphthalene-2,7-disulphonic acid

C16H13N3O7S2 (423.0195)


5-Amino-4-hydroxy-3-(phenylazo)-2,7-naphthalenedisulfonic acid is a food dye.

   

Gemcitabine diphosphate

[({[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

C9H13F2N3O10P2 (423.0044)


Gemcitabine diphosphate is a metabolite of gemcitabine. Gemcitabine is a nucleoside analog used as chemotherapy. It is marketed as Gemzar by Eli Lilly and Company. (Wikipedia)

   

Carboxyamidotriazole

5-amino-1-{[3,5-dichloro-4-(4-chlorobenzoyl)phenyl]methyl}-1H-1,2,3-triazole-4-carboxamide

C17H12Cl3N5O2 (423.0057)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C1971 - Angiogenesis Activator Inhibitor D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators D000970 - Antineoplastic Agents C93038 - Cation Channel Blocker

   
   

Arcyriarubin B 6-O-sulfate

Arcyriarubin B 6-O-sulfate

C20H13N3O6S (423.0525)


   
   
   

Glucoiberin

Glucoiberin

C11H21NO10S3 (423.0328)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

3-(Methylsulfinyl)propylglucosinolate

3-(Methylsulfinyl)propylglucosinolate

C11H21NO10S3 (423.0328)


   

3-Methylsulphinylpropyl glucosinolate

3-Methylsulphinylpropyl glucosinolate

C11H21NO10S3 (423.0328)


   

3-Methylsulfinylpropyl glucosinolate

3-Methylsulfinylpropyl glucosinolate

C11H21NO10S3 (423.0328)


   

Glucoiberin (3-methylsulfinylpropylglucosinolate)

Glucoiberin (3-methylsulfinylpropylglucosinolate)

C11H21NO10S3 (423.0328)


   

O-Desmethyltolrestat sulfate

O-Desmethyltolrestat sulfate

C15H12F3NO6S2 (423.0058)


   

Cefadyl

3-[(acetyloxy)methyl]-8-oxo-7-[2-(pyridin-4-ylsulfanyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C17H17N3O6S2 (423.0559)


   

Thiazolidine, 3-[(4-methyl-3,5-dinitrophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

Thiazolidine, 3-[(4-methyl-3,5-dinitrophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C17H17N3O6S2 (423.0559)


   

2-CHLORO-4-((3-(2,6-DICHLOROPHENYL)-5-ISOPROPYLISOXAZOL-4-YL)METHOXY)BENZALDEHYDE

2-CHLORO-4-((3-(2,6-DICHLOROPHENYL)-5-ISOPROPYLISOXAZOL-4-YL)METHOXY)BENZALDEHYDE

C20H16Cl3NO3 (423.0196)


   

ytterbium(iii) acetate hydrate

ytterbium(iii) acetate hydrate

C6H17O10Yb (423.021)


   

Platinum,dichlorobis(pyridine)-, (SP-4-2)-

Platinum,dichlorobis(pyridine)-, (SP-4-2)-

C10H10Cl2N2Pt+ (422.9869)


   

BIS(2-HYDROXYETHYL)DITHIOCARBAMIC ACID COPPER SALT

BIS(2-HYDROXYETHYL)DITHIOCARBAMIC ACID COPPER SALT

C10H20CuN2O4S4 (422.9602)


   

1-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-((2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY)PHENYL)UREA

1-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-((2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY)PHENYL)UREA

C19H13ClF3N3O3 (423.0597)


   

dichloroplatinum,pyridine

dichloroplatinum,pyridine

C10H10Cl2N2Pt (422.9869)


   

2,7-Naphthalenedisulfonicacid, 4-(benzoylamino)-5-hydroxy-

2,7-Naphthalenedisulfonicacid, 4-(benzoylamino)-5-hydroxy-

C17H13NO8S2 (423.0083)


   

ethyl 5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazine-6-carboxylate

ethyl 5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazine-6-carboxylate

C19H13ClF3N3O3 (423.0597)


   
   
   

n-methylbis(heptafluorobutyramide)

n-methylbis(heptafluorobutyramide)

C9H3F14NO2 (422.994)


   

Gemcitabine 5-diphosphate

Gemcitabine 5-diphosphate

C9H13F2N3O10P2 (423.0044)


   

3,5-dichloro-2-hydroxy-N-(4-methoxy-[1,1-biphenyl]-3-yl)benzenesulfonamide

3,5-dichloro-2-hydroxy-N-(4-methoxy-[1,1-biphenyl]-3-yl)benzenesulfonamide

C19H15Cl2NO4S (423.0099)


BMS-303141 is a potent, cell-permeable ATP-citrate lyase (ACL) inhibitor with an IC50 of 0.13 μM.

   

3-(4-Benzenesulfonyl-thiophene-2-sulfonylamino)-phenylboronic acid

3-(4-Benzenesulfonyl-thiophene-2-sulfonylamino)-phenylboronic acid

C16H14BNO6S3 (423.0076)


   

1-Deazo-Thiamin Diphosphate

1-Deazo-Thiamin Diphosphate

C13H19N3O7P2S (423.0419)


   

3-Deazo-Thiamin Diphosphate

3-Deazo-Thiamin Diphosphate

C13H19N3O7P2S (423.0419)


   

Adenosine 3,5-bismonophosphate(4-)

Adenosine 3,5-bismonophosphate(4-)

C10H11N5O10P2-4 (422.9981)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-Phosphoadenosine 5-phosphate

2-Phosphoadenosine 5-phosphate

C10H11N5O10P2-4 (422.9981)


   

2,7-Naphthalenedisulfonic acid, 5-amino-4-hydroxy-3-(phenylazo)-

2,7-Naphthalenedisulfonic acid, 5-amino-4-hydroxy-3-(phenylazo)-

C16H13N3O7S2 (423.0195)


   

[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z)-4-methylsulfinyl-N-sulfooxybutanimidothioate

[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z)-4-methylsulfinyl-N-sulfooxybutanimidothioate

C11H21NO10S3 (423.0328)


   

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z)-4-methylsulfinyl-N-sulfooxybutanimidothioate

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z)-4-methylsulfinyl-N-sulfooxybutanimidothioate

C11H21NO10S3 (423.0328)


   

5-bromo-N-[4-[5-(2-methylphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-2-furancarboxamide

5-bromo-N-[4-[5-(2-methylphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-2-furancarboxamide

C20H14BrN3O3 (423.0218)


   

2-[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazole

2-[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazole

C19H10ClF4N3O2 (423.0398)


   

5-chloro-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-(phenylmethyl)sulfonyl-4-pyrimidinecarboxamide

5-chloro-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-(phenylmethyl)sulfonyl-4-pyrimidinecarboxamide

C16H14ClN5O3S2 (423.0227)


   

2-Amino-2-deoxyadenosine 5-diphosphate(3-)

2-Amino-2-deoxyadenosine 5-diphosphate(3-)

C10H13N6O9P2-3 (423.0219)


   

2-[Methyl-[6-sulfooxy-5-(trifluoromethyl)naphthalene-1-carbothioyl]amino]acetic acid

2-[Methyl-[6-sulfooxy-5-(trifluoromethyl)naphthalene-1-carbothioyl]amino]acetic acid

C15H12F3NO6S2 (423.0058)


   

Cephapirin

Cephapirin

C17H17N3O6S2 (423.0559)


A cephalosporin with acetoxymethyl and 2(pyridin-4-ylsulfanyl)acetamido substituents at positions 3 and 7, respectively, of the cephem skeleton. It is used (as its sodium salt) as an antibiotic, being effective against gram-negative and gram-positive organisms. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Adenosine 3,5-bismonophosphate(4-)

Adenosine 3,5-bismonophosphate(4-)

C10H11N5O10P2 (422.9981)


An organophosphate oxoanion arising from deprotonation of the phosphate OH groups of adenosine 3,5-bismonophosphate; major species at pH 7.3.

   

{3-[5-hydroxy-4-(1h-indol-3-yl)-2-oxopyrrol-3-yl]-1h-indol-6-yl}oxidanesulfonic acid

{3-[5-hydroxy-4-(1h-indol-3-yl)-2-oxopyrrol-3-yl]-1h-indol-6-yl}oxidanesulfonic acid

C20H13N3O6S (423.0525)


   

methyl (3r)-4',5-dichloro-1,2-dihydro-8',13'-diazaspiro[indole-3,10'-tetracyclo[7.6.0.0²,⁷.0¹¹,¹⁵]pentadecane]-1'(9'),2',4',6',11',14'-hexaene-12'-carboxylate

methyl (3r)-4',5-dichloro-1,2-dihydro-8',13'-diazaspiro[indole-3,10'-tetracyclo[7.6.0.0²,⁷.0¹¹,¹⁵]pentadecane]-1'(9'),2',4',6',11',14'-hexaene-12'-carboxylate

C22H15Cl2N3O2 (423.0541)


   

[(4-methanesulfinyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxysulfonic acid

[(4-methanesulfinyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxysulfonic acid

C11H21NO10S3 (423.0328)


   

(6r,7r)-3-[(acetyloxy)methyl]-7-{[1-hydroxy-2-(pyridin-4-ylsulfanyl)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6r,7r)-3-[(acetyloxy)methyl]-7-{[1-hydroxy-2-(pyridin-4-ylsulfanyl)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C17H17N3O6S2 (423.0559)


   

[(z)-{4-[(s)-methanesulfinyl]-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene}amino]oxysulfonic acid

[(z)-{4-[(s)-methanesulfinyl]-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene}amino]oxysulfonic acid

C11H21NO10S3 (423.0328)


   

[(z)-{4-[(r)-methanesulfinyl]-1-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene}amino]oxysulfonic acid

[(z)-{4-[(r)-methanesulfinyl]-1-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene}amino]oxysulfonic acid

C11H21NO10S3 (423.0328)


   

n-[(1e)-2-(5-bromo-1h-indol-3-yl)ethenyl]-2-(7-hydroxy-1h-indol-3-yl)-2-oxoacetamide

n-[(1e)-2-(5-bromo-1h-indol-3-yl)ethenyl]-2-(7-hydroxy-1h-indol-3-yl)-2-oxoacetamide

C20H14BrN3O3 (423.0218)


   

[(e)-(4-methanesulfinyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxysulfonic acid

[(e)-(4-methanesulfinyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxysulfonic acid

C11H21NO10S3 (423.0328)